Hibernation during Hypoxia in Cardiomyocytes
ROLE OF MITOCHONDRIA AS THE O2 SENSOR*

G. R. Scott BudingerDagger , Jacques Duranteau§, Navdeep S. Chandel, and Paul T. Schumacker

From Pulmonary and Critical Care Medicine, The University of Chicago, Chicago, Illinois 60637

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

During myocardial hibernation, decreases in coronary perfusion elicit inhibition of contraction, suggesting that energy demand is attenuated. We previously found an inhibition of contraction and O2 consumption during hypoxia (3% O2; PO2 = 20 torr for >2 h) in cardiomyocytes, which was reversible after reoxygenation. This study sought to determine whether mitochondria function as cellular O2 sensors mediating this response. Embryonic cardiomyocytes were studied under controlled O2 conditions. Hypoxia produced no acute decrease in mitochondrial potential as assessed using tetramethylrhodamine ethylester (TMRE). Cellular [ATP] was preserved throughout hypoxia, as assessed using the probe Magnesium Green. Thus, ATP synthesis and utilization remained closely coupled. Cells adapted to hypoxia for >2 h exhibited a 4% increase in mitochondrial potential upon reoxygenation, suggesting that a partial inhibition of cytochrome c oxidase had existed. To test whether the oxidase serves as an O2 sensor, azide was administered (1 mM) to simulate the effects of hypoxia by lowering the Vmax of the oxidase. The effects of azide on contraction and mitochondrial potential mimicked the response to hypoxia. We conclude that partial inhibition of cytochrome oxidase during hypoxia allows mitochondria to function as the O2 sensor mediating the decreases in ATP utilization and O2 consumption during hypoxia.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Regional decreases in myocardial oxygen delivery have been shown to result in decreased contractile activity and O2 consumption in a phenomenon termed hibernating myocardium. For example, Arai et al. (1) induced a 30% reduction in coronary blood flow in swine and observed an early depletion of ATP and phosphocreatine (PCr)1 and an increase in tissue lactate followed by a later recovery of PCr and lactate, despite continued hypoperfusion and impaired contraction. During progressive decreases in coronary blood flow, the same group found that regional decreases in contractile function occurred without a sustained decrease in the PCr to ATP ratio (2). Other investigators have also found evidence of myocardial hibernation in intact hearts (3-5). Collectively these results indicate that the myocardium can develop significant contractile inhibition during reductions in blood flow without apparent evidence of ischemia. This would appear to represent an adjustment in ATP demand in response to a decrease in regional O2 supply, which could protect the myocardium from ischemic injury in states where blood flow is reduced more severely (6). However, the mechanisms underlying this response are not fully known (5).

The inference that intact myocardium can down-regulate energy requirements and ATP demand during hypoxia suggests that cardiac myocytes may behave similarly. In contracting embryonic cardiomyocytes, we previously observed decreases in contractile motion and in the rate of O2 uptake during prolonged moderate hypoxia (PO2 = 20-40 torr for 1-2 h) (7). Moreover, this inhibition was reversible within 3 h after return to normoxia, which suggests that cardiac myocytes can detect moderate hypoxia and initiate a suppression of ATP utilization in response. Recently, Silverman et al. (8) found decreases in extent of shortening in rat cardiac myocytes after incubation under 1% O2 for 48 h, which is consistent with our observations and reveals that this response is not unique to embryonic cells. Collectively, these findings suggest that cardiomyocytes can respond to moderate hypoxia by reversibly decreasing contractile activity, at PO2 levels that should have been sufficient to sustain mitochondrial respiration. Although hibernating myocardium is a phenomenon of intact hearts by definition, studies of cellular responses to hypoxia may provide insight into the mechanisms involved in the intact ventricle.

A fundamental question in understanding the mechanism underlying the response to hypoxia relates to how cardiac myocytes detect changes in PO2. An ability to adjust cellular respiration in response to PO2 implies the existence of a sensor capable of detecting changes within the physiological range. It is conceivable that such an O2 sensor could then activate a signaling pathway leading to a down-regulation of contractile motion, energy utilization, and oxygen demand. Recent evidence points to the mitochondrial electron transport chain as a possible site of O2 transduction (9). In this regard, we previously found a reversible inhibition in cytochrome c oxidase Vmax during hypoxia, as evidenced by PO2-dependent decreases in TMPD-ascorbate respiration (7). Moreover, kinetic studies of isolated bovine heart cytochrome oxidase confirmed the existence of PO2-dependent alterations in Vmax (10). A PO2-dependent change in the kinetic activity of cytochrome oxidase could elicit changes in mitochondrial redox state, which could confer a sensitivity to PO2 and allow the mitochondria to act as the cellular O2 sensor. In the present study we assessed the effects of moderate hypoxia and reoxygenation on mitochondrial transmembrane potential to determine whether changes in the function of the oxidase were apparent in the intact myocyte, and whether under normoxic conditions the cytochrome c oxidase inhibitor sodium azide could mimic the reversible decrease in contraction observed during hypoxia.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Cardiac Myocyte Isolation-- Myocytes were isolated using a method modified from Barry et al. (11) and previously described (7). Briefly, hearts of 10-11-day-old chick embryos were removed and placed in Hanks' balanced salt solution without magnesium and without calcium (Life Technologies, Inc.). The ventricles were minced, and the cells were dissociated using four to six cycles of trypsin (0.025%, Life Technologies, Inc.) degradation at 37 °C with gentle agitation. Trypsin digestion was halted after 8 min by transferring dissociated cells to a trypsin inhibitor solution. After filtering (100 µm), the cells were centrifuged for 5 min at 1200 rpm at 4 °C and then resuspended in nutritive media (54% Barry's solution (in mM: NaCl (116), KCl (1.3), NaHCO3 (22), MgSO4 (0.8), NaH2PO4 (1.0), CaCl2 (0.87), glucose (5.6)), 40% M199 with Earle's salts (Life Technologies, Inc.), 6% heat-inactivated fetal bovine serum and penicillin (100 units/ml), and streptomycin (100 mg/ml)). These cells were then placed in a large Petri dish in a humidified incubator (5% CO2, 95% air at 37 °C) for 45 min to allow early adherence of fibroblasts. The nonadherent cells were then enumerated (hemacytometer), their viability confirmed at >85% (trypan blue) and between 0.6 and 1.5 × 106 cells were plated on glass coverslips (25 mm) in nutritive medium. Cell yield averaged 5-6 × 105 cells per embryo. Cells were maintained in a humidified incubator for 2-3 days, at which point synchronous contractions of the monolayer were noted. All experiments were performed on spontaneously contracting cells at day 3 or 4 after isolation, at which point cell viability was typically >99%.

Perfusion System-- Synchronously contracting cardiac myocytes on 25-mm glass coverslips were placed in a stainless steel flow-through chamber (2-ml volume). This flow-through chamber was inserted into a heated platform (37 °C) (Warner Instruments) on an inverted microscope stage. A water-jacketed glass equilibration column (37 °C) mounted above the microscope stage was used to equilibrate the perfusate to known oxygen tensions. The perfusate used during experiments consisted of a buffered salt solution (in mM: NaCl (117), KCl (4.0), NaHCO3 (18), MgSO4 (0.8), NaH2PO4 (1.0), CaCl2 (1.21), glucose (5.6)) that was bubbled with 5% CO2 at different O2 concentrations. The gas used to control the PO2 and PCO2 of the perfusate was supplied by a calibrated precision mass flow controller (Cameron Instruments). A short length of stainless steel or polyethylethylketone tubing was used to connect the equilibration column to the flow-through chamber to minimize the leakage of ambient O2 into the perfusate. In some studies, the PO2 in the chamber was confirmed using an optical phosphorescence quenching method (Oxyspot, Medical Systems Inc.) In those studies, a porphin-based dye (20 µM) bound to albumin (5% w/v) was added to the perfusate (12, 13) and the fiberoptic light guide was positioned above the upper glass coverslip of the flow-through chamber. In those studies, the PO2 in the chamber was determined from the O2-dependent phosphorescence decay following a pulse of excitation light generated by a xenon flash lamp.

Data Acquisition and Analysis-- The inverted microscope was equipped for epifluorescent illumination and included a xenon light source (75 W), a cooled 12-bit digital CCD camera (Princeton Instruments), a shutter and filter wheel (Sutter), and appropriate excitation and emission filters. Data were acquired and analyzed using Metamorph software (Universal Imaging).

Contractile motion of cells was recorded at video rates on magnetic tape using a high resolution video camera (Hammamatsu), as described previously (7). Briefly, the cells were illuminated with visible light at low intensity using Hoffman modulation optics (Modulation Optics, Inc.). This optical system tended to accentuate the changes in surface topology that were apparent during contraction. Approximately 1 min of contractile motion was recorded at each stage for later analysis. Recorded sequential video frames were digitized and pixels were assigned an intensity value ranging from 0 to 255. For each pixel, the absolute change in intensity was summed over ~250 frames. These summed changes in intensity were summed for all pixels, providing a single measure of motion in the field that consistently described the motion that already was evident by inspection. The contraction analysis was carried out as a series of macroinstructions using the Metamorph software (Universal Imaging).

Measurement of Mitochondrial Transmembrane Potential-- The mitochondrial transmembrane potential was measured using the cationic dye tetramethylrhodamine ethylester (TMRE, Molecular Probes). This fluorophore enters the cells and is accumulated in mitochondria according to the Nernst equation (14, 15) and has been used previously to assess relative changes in mitochondrial potential. Unlike with rhodamine 123, we did not observe quenching of cellular fluorescence with TMRE unless excessive dye was loaded into the cells. Excitation (535 nm), dichroic (565 nm), and emission (610 nm) filters were used (Chroma Technology). To minimize photobleaching of the dye, the excitation intensity was attenuated with a neutral density filter, and exposure times were limited to 100 ms. Coverslips with spontaneously contracting cells were loaded for 1 h with TMRE (100 nM) in a humidified incubator at 37 °C. The cells were then placed in the flow-through chamber and continuously perfused with the buffered salt solution containing TMRE (10 nM). After allowing 60-90 min for equilibration, a digital image was obtained of a field of ~40 cells using a 40× oil immersion objective lens. Using the data acquisition software, individual cells or clusters of several (<10) cells were identified as regions of interest, and background was identified as an area without cells or with minimal cellular fluorescence. Subsequently, sequential digital images were obtained every 1-3 min, and the average fluorescence intensity for all of the cell regions and background was recorded for later analysis. TMRE fluorescence intensity is reported as the average of the fluorescence of all identified cell regions, less background, for each coverslip.

Assessment of Cellular ATP Hydrolysis-- ATP has a greater affinity for Mg2+ than does ADP, and the cytosolic ionized magnesium concentration increases during ATP hydrolysis. The increases in cytosolic [Mg2+] can be assessed using the intracellular fluorescent indicator Magnesium Green (MgG), and the behavior of this dye in cardiomyocytes has been studied in detail by Leyssens et al. (16). We measured MgG fluorescence (excitation 480 nm, emission 535 nm) in contracting cardiomyocytes during prolonged hypoxia and reoxygenation to assess ATP hydrolysis. Cells on coverslips were loaded with MgG in the acetoxymethyl ester form (5 µM, Molecular Probes) for 30 min at 37 °C in a humidified incubator. Subsequently, the cells were transferred to the flow-through chamber and perfused with buffered salt solution under controlled O2 and CO2 conditions. To abolish the capacity for anaerobic glycolysis, 2-deoxyglucose (20 mM) was added to the perfusate, along with pyruvate (5 mM) to support mitochondrial respiration. Cells continued to contract spontaneously under these conditions. Fluorescent images were collected for multiple regions of interest every 60 s, using 100-ms exposure times. Average fluorescence was then calculated for each coverslip and analyzed as a percentage of initial values after subtraction of background fluorescence. At the end of the study, the mitochondrial uncoupler FCCP was added (5 µM) to induce ATP hydrolysis to confirm activity of the probe.

Reagents-- In different experiments the cells were treated with the mitochondrial uncoupler FCCP, the electron transport inhibitor myxothiazol, the mitochondrial ATP synthase inhibitor oligomycin and 2,3-butanedione monoxime (BDM) (Sigma). Using a spectrofluorometer, all of these compounds were found to exhibit insignificant fluorescence at 565 nm or quenching when excited at 530 nm (data not shown).

Statistical Analysis-- Replicate experiments were carried out independently using separate coverslips with cells. Data were analyzed using analysis of variance on the pooled data from the intervention and control experiments. Statistical significance was determined at the 0.05 level. Data are presented as mean values ± S.E.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Effects of Prolonged Moderate Hypoxia on Contractile Motion in Cultured Cardiomyocytes-- The contractile response to moderate hypoxia and reoxygenation was studied in cultured cardiomyocytes (Fig. 1). After 2 h under normoxic conditions (PO2 = 100 torr), the perfusate PO2 was reduced to ~20 torr (3% O2) for 3 h. No immediate effect on contraction was noted, but within 1-2 h a significant decrease in motion was consistently observed. When the perfusate O2 tension was returned to 100 torr, no immediate effect on contractile motion was noted. However, a progressive return of contraction developed over 2-3 h, and no significant difference from control levels was apparent at 3 h. These reversible decreases in contraction were similar to those noted previously (7).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of hypoxia on total motion of spontaneously contracting cardiomyocytes during perfusion with buffered salt solutions under controlled O2 conditions. Hypoxia (PO2 = 20 torr; 3% O2) was initiated after base-line measurements. Recovery to PO2 = 100 torr; (14% O2) was initiated at 180 min, but restoration of contractile motion required ~3 h to reach base-line values (n = 4, p < 0.01).

Effect of Prolonged Moderate Hypoxia on [ATP] in Contracting Cardiomyocytes-- Previous studies of noncontracting cardiomyocytes in suspension indicated that prolonged moderate hypoxia was associated with a decrease in oxygen consumption rate without a decrease in cellular ATP or phosphocreatine concentrations (7). To determine whether ATP depletion occurs during prolonged hypoxia in contracting cells, MgG fluorescence was used to assess ATP hydrolysis (16). To determine the capability of this dye to detect ATP hydrolysis, cells loaded with MgG were imaged every 60 s during continuous normoxia (Fig. 2). After 4 min, the mitochondrial uncoupler FCCP was administered to limit ATP synthesis, and an abrupt increase in fluorescence was noted, consistent with a rise in intracellular Mg2+. In other cells loaded identically, the ATP synthase inhibitor oligomycin (10 µg/ml) produced a similar abrupt increase in fluorescence, as predicted (Fig. 3). To determine the effects of hypoxia on ATP hydrolysis, cells loaded with MgG were imaged every 5 min during 2.5 h of incubation at PO2 = 20 torr or 100 torr. As shown in Fig. 4, a gradual loss of fluorescence was noted in both groups, which appeared to be a consequence of the progressive photobleaching behavior of the MgG probe. However, no difference was noted between control and hypoxic cells. Moreover, the absence of an increase in fluorescence during hypoxia suggested that cytosolic [Mg2+] did not increase as a result of increased ATP hydrolysis. However, when ATP synthesis was halted by FCCP (5 µM) at the end of the study, a marked increase in fluorescence indicating an increase in [Mg2+] was noted.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of mitochondrial uncoupling on MgG fluorescence in spontaneously contracting cardiomyocytes. Cells loaded with MgG were perfused under normoxic conditions (PO2 = 100 torr; 14% O2) and administered FCCP (5 µM) to inhibit oxidative phosphorylation. The marked increase in fluorescence suggests an increase in Mg2+ released as a result of ATP hydrolysis.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of mitochondrial ATP synthase inhibition on MgG fluorescence in spontaneously contracting cardiomyocytes. Cells loaded with MgG were perfused under normoxic conditions (PO2 = 100 torr; 14% O2) and administered oligomycin (10 µg/ml) to inhibit oxidative phosphorylation. The marked increase in fluorescence suggests an increase in Mg2+ release as a result of ATP hydrolysis.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of hypoxia on MgG fluorescence in spontaneously contracting cardiomyocytes. Under base-line conditions, cells loaded with MgG were perfused with normoxic (PO2 = 100 torr; 14% O2) solution. At t = 30 min, perfusate PO2 was reduced to 20 torr (3% O2) in the hypoxia group while controls remained normoxic. At t = 180 min, the mitochondrial uncoupler FCCP (5 µM) was administered to elicit ATP hydrolysis. No statistical difference between groups was detected (n = 3).

Effect of Mitochondrial Inhibitors on Mitochondrial Membrane Potential as Assessed Using TMRE Fluorescence-- Studies were carried out to confirm that the fluorescent probe TMRE behaved in a manner consistent with that expected for a mitochondrial potentiometric dye. Administration of the mitochondrial uncoupler FCCP would be expected to rapidly dissipate the mitochondrial electrochemical gradient. As predicted, addition of FCCP (5 µM) to the perfusate of contracting cardiac myocytes at t = 0 produced a rapid and marked decrease in fluorescence indicating a loss of potential (Fig. 5a). Mitochondrial potential is generated by flux through the electron transport chain, which is coupled to the extrusion of protons from the matrix. Inhibitors of electron transport should decrease proton extrusion, resulting in a decrease in the potential across the inner mitochondrial membrane. Accordingly, the mitochondrial bc1 complex inhibitor myxothiazol (50 ng/ml) was added to the perfusate of contracting cardiac myocytes.(Fig. 5b). This produced a significant decrease in TMRE fluorescence, consistent with a marked decrease in potential.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   a, TMRE fluorescence in cardiomyocytes administered FCCP (5 µM) to inhibit oxidative phosphorylation. FCCP was administered at t = 0 s, and cells were imaged every 60 s. Cells not given FCCP served as time controls. Mitochondrial inhibition produced a significant decrease in TMRE fluorescence, as predicted for a potentiometric dye (n = 3). b, TMRE fluorescence in cardiomyocytes administered myxothiazol (50 ng/ml) to inhibit oxidative phosphorylation. Myxothiazol was administered at t = 0 s and cells were imaged every 60 s. Cells not given myxothiazol served as controls (n = 3).

Mitochondrial membrane potential is consumed by the F1F0 ATP synthase. The synthase allows protons to move down their electrochemical gradient as they enter the matrix, resulting in the phosphorylation of ADP to ATP using the resulting free energy release. Inhibition of ATP synthase should therefore cause hyperpolarization of the mitochondrial membrane. As shown in Fig. 6, addition of oligomycin (10 µg/ml) to the perfusate of contracting cardiac myocytes resulted in a significant increase in TMRE fluorescence. Similarly, an inhibition of ATP utilization should cause a decrease in the rate of ATP synthesis by limiting the supply of ADP to the mitochondria, which should produce hyperpolarization of the mitochondrial potential. To confirm this, BDM (30 mM) was added to the perfusate of contracting cardiac myocytes at t = 0 (Fig. 7). As an inhibitor of Ca2+-dependent actin-myosin interaction, BDM produced an immediate and significant increase in TMRE fluorescence, which was accompanied by an immediate cessation of contraction. Collectively, these results show that TMRE serves as an appropriate qualitative measurement of mitochondrial membrane potential.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   TMRE fluorescence in cardiomyocytes administered oligomycin to inhibit oxidative phosphorylation. Oligomycin (10 µg/ml) was administered starting at t = 0 s, and cells were imaged every 60 s. Cells not given oligomycin served as controls. Mitochondrial ATP synthase inhibition produced a significant increase in TMRE fluorescence, as predicted for a potentiometric dye (n = 3). The later decrease in fluorescence likely represents an artifact due to cell deterioration.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 7.   Effects of decreased ATP utilization on TMRE fluorescence in spontaneously contracting cardiomyocytes. BDM inhibits Ca2+-dependent actin-myosin interaction in cardiac muscle, resulting in a decrease in ADP supply to mitochondria. The subsequent decrease in ATP utilization should result in a hyperpolarization of the mitochondrial membrane. BDM (30 mM) given at t = 0 s caused an immediate cessation of contractile motion, and elicited a sustained increase in fluorescence in the treated cells while fluorescence in the control cells remained unchanged (n = 3).

Effect of Hypoxia and Reoxygenation on Mitochondrial Membrane Potential-- Mitochondrial membrane potential was assessed during hypoxia under two different experimental protocols. In the first, TMRE fluorescence in contracting cells was measured in images obtained as the perfusate O2 tension was decreased from 100 to 25 torr within 10 min (acute hypoxia). As shown in Fig. 8, acute hypoxia produced no acute change in TMRE fluorescence, which suggests that membrane potential was maintained. In the second, mitochondrial potential was recorded in contracting cells that had been perfused for 2 h at PO2 = 25 torr, as the PO2 was rapidly increased from 25 to 100 torr (acute reoxygenation). Fig. 9a shows that TMRE fluorescence increased significantly during reoxygenation, which suggests that an increase in membrane potential had occurred. This relative hyperpolarization is consistent with an increase the rate of electron transport during acute reoxygenation, compared with the rate of ATP utilization. Interestingly, the change in membrane potential did not occur until ~4 min after the equilibration mixture was switched to normoxia. In separate studies, the PO2 within the cell chamber was assessed under identical conditions of reoxygenation using a phosphorescence-quenching method (12). Those measurements revealed that the PO2 within the chamber reached a value of ~60 torr at 4 min, which suggested that the delay in response was caused by the slow response in reoxygenating the system (Fig. 9b).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 8.   TMRE fluorescence in spontaneously contracting cardiomyocytes perfused with normoxic (PO2 = 100 torr; 14% O2) solution. Cells were imaged every 60 s for 5 min, at which point the PO2 in the perfusate was rapidly decreased to 20 torr (hypoxia, 3% O2) or maintained at normoxia. No significant difference in fluorescence response was detected between the two groups (n = 3).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 9.   a, TMRE fluorescence in spontaneously contracting cardiomyocytes perfused continuously with hypoxic media (PO2 = 25 torr) for 90 min. At t = 0 s, the gas in the equilibration column was increased to PO2 = 100 torr (14% O2, reoxygenation) or maintained at 25 torr (continued hypoxia) while fluorescence was measured every 60 s for 600 s. A significant increase in fluorescence was detected in the reoxygenation group compared with hypoxic controls (p < 0.05). b, change in PO2 within the flow-through chamber after switching the gas mixture to normoxia at t = 0 s.

Effect of Azide on Contraction and Mitochondrial Potential-- To test whether a partial inhibition of cytochrome oxidase function could elicit the same response as moderate hypoxia, sodium azide (1 mM) was added to the perfusate in cells maintained under normoxic conditions. In preliminary studies this concentration of azide was found to be sufficient to reduce the Vmax of cytochrome oxidase, but too low to limit respiration in cells. When azide was added, no immediate effect was seen but a progressive suppression in contractile motion developed over 2 h (Fig. 10). Washout of the azide required ~10 min and was associated with a progressive return of contractile motion that mimicked the response to hypoxia. To assess the effects of azide (1 mM) on mitochondrial potential, cells loaded with TMRE were imaged every minute for 5 min, at which point sodium azide (1 mM) was added to the perfusate (Fig. 11). No acute decrease in potential was observed, suggesting that membrane potential was preserved. In other cells loaded with TMRE and incubated with azide for 2 h, washout of the azide was associated with an acute increase in membrane potential, suggesting that a relative hyperpolarization of the membrane had developed. These responses were similar to those seen during onset and recovery from moderate hypoxia.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 10.   Contractile motion of spontaneously contracting cardiomyocytes perfused with normoxic (PO2 = 100 torr; 14% O2) solution. Azide (1 mM) was added after base-line measurements at t = 0 min. At t = 2 h, azide was removed from the perfusate and cells were allowed to recover for 2 h (n = 3).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 11.   TMRE fluorescence in of spontaneously contracting cardiomyocytes perfused with normoxic (PO2 = 100 torr; 14% O2) solution. Fluorescence images were obtained every 60 s for 700 s. In one group (Azide on), sodium azide (1 mM) was added to the perfusate at t = 300 s. A second group of cells had been continuously superfused with azide (1 mM) for 2 h prior to data collection. At t = 300 s, azide was removed from the perfusate as the cells continued to be imaged. A significant increase in fluorescence was detected after washout of the azide (n = 3).

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Myocardial hibernation is a chronic abnormality of contractile function associated with coronary hypoperfusion (17). This dysfunction is reversed if coronary blood flow is restored, which suggests that the abnormality is not a consequence of ischemic cellular damage. Studies using 31P NMR spectroscopy suggest inorganic phosphate levels are not increased during hibernation, which supports the view that the attenuation of contraction is not a consequence of a reduction in energy stores (5). However, the mechanisms underlying myocardial hibernation are not fully understood.

We previously reported that spontaneously contracting cardiomyocytes down-regulate contractile motion and O2 consumption during prolonged (1-2 h) moderate hypoxia (PO2 = 25 torr) (7). Cells kept under those conditions for 24 h showed no decrement in viability, suggesting that the inhibition was not a consequence of cell damage. Similar findings of decreased contractile motion with sustained viability have recently been reported in rat cardiomyocytes cultured under 1% O2 for 48 h (8). That study indicates that our results are not unique to embryonic cells. Moreover, it extends our previous work by demonstrating that hibernating cardiac myocytes were more tolerant to acute severe hypoxic challenge, in terms of the time required to elicit ATP-depletion. These studies suggest that a phenomenon similar to myocardial hibernation develops in cardiac myocytes during prolonged hypoxia, which affords protection from anoxic stress and is reversible within hours after recovery to normoxic culture conditions.

Hypoxia Reversibly Decreases Contraction-- In this study, cardiomyocytes superfused at PO2 = 20 torr showed progressive decreases in contractile motion that reached 40% of control levels within ~2 h. Recovery to PO2 = 100 torr was associated with a recovery of contraction, although several hours were required to reach base-line levels. We previously observed that cardiomyocytes maintained under normoxic conditions for ~6 h showed no significant changes in contractile motion, so the observed response to hypoxia cannot be explained by the effects of time alone. During brief exposures to hypoxia, Rumsey et al. (18) found that adult rat cardiac myocytes could maintain normal rates of O2 consumption until the extracellular PO2 fell to less than ~7 torr (18). Moreover, the observations that cells continued to function normally during the first hour of hypoxia and that the decreases in contraction were reversible suggest that the effects of hypoxia we found could not be explained by an O2 supply limitation of mitochondrial ATP synthesis.

Nevertheless, to test whether hypoxia elicited ATP supply limitation, we used Magnesium Green to assess ATP hydrolysis in contracting cells during moderate hypoxia. The fluorescence of this dye increases with the intracellular Mg2+ concentration, which increases during ATP hydrolysis because ATP has a higher affinity for Mg2+ than does ADP (16). Indeed, marked increases in fluorescence were seen in normoxic cells treated with the mitochondrial uncoupler FCCP or with the ATP synthase inhibitor oligomycin, both of which should inhibit oxidative phosphorylation and cause ATP depletion. However, no increase in MgG fluorescence was seen during prolonged exposure to PO2 = 20 torr, suggesting that ATP hydrolysis was minimal. We previously measured [ATP] and [PCr] in quiescent cardiomyocytes and found that cellular levels were preserved during prolonged moderate hypoxia. The present study extends those results by showing that ATP levels are similarly preserved in contracting cells during prolonged hypoxia.

To further test whether hypoxia elicited ATP supply limitation, we assessed mitochondrial potential using the dye TMRE. Mitochondrial membrane potential provides the driving force for ATP synthesis. The potential is generated by the supply of NADH through the matrix dehydrogenases and electron flux through electron transport chain. The ATP synthase uses the energy from mitochondrial membrane potential to synthesize ATP from ADP plus inorganic phosphate. In steady state, the mitochondrial membrane potential therefore reflects a balance between the rate of electron transport and the rate of ATP utilization by the cell. An inhibition within the electron transport chain during hypoxia would therefore result in a decrease in electron flux and a depolarization of the membrane, while a sudden inhibition of ATP utilization or an inhibition of the ATP synthase should produce a relative hyperpolarization. Indeed, these responses were observed when electron transport was inhibited with myxothiazol or when the ATP synthase was inhibited with oligomycin. Therefore, if hypoxia limited ATP synthesis by restricting mitochondrial electron transport, then a profound decrease in membrane potential should have been evident at the start of hypoxia in the TMRE studies. But mitochondrial potential was maintained during acute hypoxia, which suggests that ATP utilization and ATP synthesis remained closely matched. This conclusion is consistent with the absence of ATP hydrolysis indicated by the MgG data. Collectively, these findings suggest that hypoxia decreases respiration in cardiomyocytes by activating a signaling pathway that causes a reduction in contraction and ATP demand, rather than by limiting ATP supply.

Hypoxia Causes a Partial Mitochondrial Inhibition-- Although mitochondrial potential was not depleted during hypoxia, small increases in potential were detected at reoxygenation. This suggests that there was a rapid increase in electron transport without a corresponding increase in ATP utilization. Such an increase would be predicted if a partial inhibition of cytochrome oxidase were rapidly removed at reoxygenation. In previous studies of the oxidase, we have observed an immediate increase in Vmax upon reoxygenation after prolonged hypoxia (9, 10, 19). We therefore conclude that the changes in mitochondrial potential at reoxygenation reflect functional changes in the kinetics of the oxidase that develop during prolonged hypoxia. These observations indicate that mitochondria can respond to changes in O2 tension within the physiological range, which could allow them to function as an O2 sensor.

Cytochrome c Oxidase Serves as an O2 Sensor-- Sodium azide is a noncompetitive inhibitor of cytochrome c oxidase (20). At high concentrations (5-10 mM) it can throttle respiration by limiting O2 consumption, resulting in an immediate cessation of contraction and depletion of mitochondrial potential. By contrast, low concentrations (<= 1 mM) merely reduce the Vmax of the enzyme without limiting basal respiration. Our previous studies indicated that prolonged hypoxia produces a reversible decrease in Vmax of the oxidase (7, 9, 10), which is not sufficient to limit basal respiration. Thus, low concentrations of azide could mimic the effects of hypoxia on the enzyme. Our observation that azide during normoxia produced the same changes in contractile function and mitochondrial potential seen during moderate hypoxia implicates cytochrome oxidase as the oxygen sensor underlying the functional response to hypoxia.

The observation that cells respond to physiological levels of O2 suggests the existence of a signal transduction pathway linking the sensor to the functional response. Some investigators have argued that cytochrome oxidase is ill-suited to function as an O2 sensor because its apparent Km for O2 is <1 µM (8, 21). Therefore, at physiological O2 concentrations the velocity of such an enzyme system would remain independent of O2 until near-anoxic conditions were reached, limiting its ability to signal changes in the physiological range. However, changes in the Vmax of the oxidase produced with hypoxia or azide (1 mM) should increase the reduction state of mitochondrial electron carriers upstream from the oxidase (19). It is conceivable that subsequent redox-linked activation of second messenger systems (22, 23) could then lead to an inhibition of ATP utilization within the cell. Although not yet confirmed, the above sequence would be consistent with (a) the previously observed changes in cytochrome oxidase Vmax during hypoxia, (b) the observed changes in mitochondrial potential during hypoxia and reoxygenation, (c) the possible delay between onset of hypoxia or reoxygenation and the changes in cell motion and ATP demand, and (d) the sustained coupling between cellular respiration and ATP demand as indicated by membrane potential and MgG. However, further study will be required to fully identify the signaling cascade(s) mediating the functional response.

Significance for Intact Tissues-- A number of similarities between the response to hypoxia in cardiomyocytes and that seen in hibernating myocardium should be noted. First, both appear to involve a matching between ATP utilization and O2 supply without evidence of ischemia. Second, both conditions are fully reversible upon restoration of base-line conditions, without loss of cell viability or necrotic damage. One notable difference is that contractile function in hibernating myocardium recovers immediately upon restoration of flow (24), whereas recovery of cardiomyocytes required 2-3 h after restoration of normoxic conditions. Although the present study provides insight into the mechanisms contributing to the response to hypoxia in cardiomyocytes, further work will be required to clarify the relationship of these findings to the events in the intact hibernating myocardium.

    FOOTNOTES

* This work was supported in part by National Institutes of Health NHLBI Grants HL32646 and HL35440.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by an American Heart Association Senior Fellowship Award.

§ Supported by Societé Française d'Anesthesie Réanimation.

To whom correspondence should be addressed: Dept. of Medicine, The University of Chicago, MC6026, 5841 S. Maryland Ave., Chicago, IL 60637. Tel.: 773-702-6790; Fax: 773-702-4736; E-mail: pschumac{at}medicine.bsd.uchicago.edu.

1 The abbreviations used are: PCr, phosphocreatine; TMPD, N,N,N',N'-tetramethyl-p-phenylenediamine; TMRE, tetramethylrhodamine ethylester; MgG, Magnesium Green; FCCP, carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone; BDM, 2,3-butanedione monoxime.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

  1. Arai, A. E., Pantely, G. A., Anselone, C. G., Bristow, J., Bristow, J. D. (1991) Circ. Res. 69, 1458-1469[Abstract]
  2. Arai, A. E., Grauer, S. E., Anselone, C. G., Pantely, G. A., Bristow, J. D. (1995) Circulation 92, 244-252[Abstract/Free Full Text]
  3. Lee, S.-C., and Downey, H. F. (1993) Cardiovasc. Res. 27, 1542-1550[Medline] [Order article via Infotrieve]
  4. Ito, B. R. (1995) Circulation 91, 2058-2070[Abstract/Free Full Text]
  5. Marban, E. (1991) Circulation 83, 681-688[Medline] [Order article via Infotrieve]
  6. Ross, J. J. (1991) Circulation 83, 1076-1082[Abstract]
  7. Budinger, G. R. S., Chandel, N., Shao, Z. H., Li, C. Q., Melmed, A., Becker, L. B., Schumacker, P. T. (1996) Am. J. Physiol. 14, L37-L53
  8. Silverman, H. S., Wei, S., Haigney, M. C. P., Ocampo, C. J., Stern, M. D. (1997) Circ. Res. 80, 699-707[Abstract/Free Full Text]
  9. Chandel, N., Budinger, G. R. S., Kemp, R. A., Schumacker, P. T. (1995) Am. J. Physiol. 268, L918-L925[Abstract/Free Full Text]
  10. Chandel, N. S., Budinger, G. R. S., Schumacker, P. T. (1996) J. Biol. Chem. 271, 18672-18677[Abstract/Free Full Text]
  11. Barry, W. H., Pober, J., Marsh, J. D., Frankel, S. R., Smith, T. W. (1980) Am. J. Physiol. 239, H651-H657[Medline] [Order article via Infotrieve]
  12. Wilson, D. F., Rumsey, W. L., Green, T. J., Vanderkooi, J. M. (1988) J. Biol. Chem. 263, 2712-2718[Abstract/Free Full Text]
  13. Lo, L. W., Koch, C. J., and Wilson, D. F. (1996) Anal. Biochem. 236, 153-160[CrossRef][Medline] [Order article via Infotrieve]
  14. Ehrenberg, B., Montana, V., Wei, M.-D., Wuskell, J. P., Loew, L. M. (1988) Biophys. J. 53, 785-794[Abstract]
  15. Farkas, D. L., Wei, M.-D., Febbroiello, P., Carson, J. H., Loew, L. M. (1989) Biophys. J. 56, 1053-1069[Abstract]
  16. Leyssens, A., Nowicky, A. V., Patterson, L., Crompton, M., and Duchen, M. R. (1996) J. Physiol. 496, 111-128 [Abstract]
  17. Opie, L. H. (1996) J. Mol. Cell. Cardiol. 28, 2403-2414[CrossRef][Medline] [Order article via Infotrieve]
  18. Rumsey, W. L., Schlosser, C., Nuutinen, E. M., Robiolio, M., Wilson, D. F. (1990) J. Biol. Chem. 265, 15392-15402[Abstract/Free Full Text]
  19. Chandel, N. S., Budinger, G. R. S., Choe, S. H., Schumacker, P. T. (1997) J. Biol. Chem. 272, 18808-18816[Abstract/Free Full Text]
  20. Petersen, L. C. (1977) Biochim. Biophys. Acta 460, 299-307[Medline] [Order article via Infotrieve]
  21. Bunn, H. F., and Poyton, R. O. (1996) Physiol. Rev. 76, 839-885[Abstract/Free Full Text]
  22. Monteiro, H. P., and Stern, A. (1996) Free Radic. Biol. Med. 21, 323-333[CrossRef][Medline] [Order article via Infotrieve]
  23. Laderoute, K. R., and Webster, K. A. (1997) Circ. Res. 80, 336-344[Abstract/Free Full Text]
  24. Heusch, G., and Schulz, R. (1996) J. Mol. Cell. Cardiol. 28, 2359-2372[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.